Preparation of pure immunoglobulins

  • Miroslav Ferenčík


Immunoglobulins are usually isolated from blood serum and only rarely from other body fluids. Different methods, yielding immunoglobulins of various purity and immunochemical activity, may be used (Table 8.1).


Kawasaki Disease Anaphylactoid Reaction Primary Immunodeficiency Disease Common Variable Immune Deficiency Relative Molecular Weight 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baker, C. J. (1977) Summary of the workshop on perinatal infections due to group B streptococcus. J. Infect. Dis. ,136, 137–52.CrossRefGoogle Scholar
  2. Baker, C. J. (1986) Group B streptococcal infection in newborns: prevention at last? New Engl. J. Med. ,314, 1702–4.CrossRefGoogle Scholar
  3. Barandun, S. and Isliker, H. (1986) Development of immunoglobulin preparations for intravenous use. Vox Sang. ,51, 157–60.CrossRefGoogle Scholar
  4. Berger, M. (1987) Immunoglobulin G subclass determination in diagnosis and management of antibody deficiency syndromes. J. Pediatr. ,110, 325–8.CrossRefGoogle Scholar
  5. Berkman, S. A., Lee, M. L. and Gale, R. P. (1990) Clinical uses of intravenous immunoglobulins. Ann. Intern. Med. ,112, 278–92.Google Scholar
  6. Bruton, O. C. (1952) Agammaglobulinaemias. Pediatrics ,9, 722–7.Google Scholar
  7. Buckley, R. M. (1982) Long term use of intravenous immune globulin in patients with primary immunodeficiency disease : inadequacy of current dosage practices and approaches to the problem. J. Clin. Immunol. ,2, 155–215.CrossRefGoogle Scholar
  8. Chirico, G., Rondini, G., Plenbani, A., Chiara, A., Massa, M. and Ugazio, A. R. (1987) Intravenous gammaglobulin therapy for prophylaxis of infection in high-risk neonates. J. Pediatr. ,110, 437–42.CrossRefGoogle Scholar
  9. Cohn, E. J. (1945) Blood proteins and their therapeutic value. Science ,101, 51–6.CrossRefGoogle Scholar
  10. Cohn, E. J., Strong, L. E., Hughes, W. L., Mulford, D. J., Ashworth, J. N., Melin, M. and Taylor, H. L. (1946) Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J. Amer. Chem. Soc. ,68, 459–75.Google Scholar
  11. Delfraissy, J. F., Tchernia, G., Laurian, Y., Wallon, C., Galanaud, P. and Dormont, J. (1985) Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura. Brit. J. Haematol. ,60, 315–22.CrossRefGoogle Scholar
  12. Engelhard, D., Waner, J. L., Kapoor, N. and Good, R. A. (1986) Effect of intravenous immune globulin on natural killer cell activity : Possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J. Pediatr. ,108, 77–81.CrossRefGoogle Scholar
  13. Etzioni, A. and Pollack, S. (1989) High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses. Autoimmunity ,3, 307–15.CrossRefGoogle Scholar
  14. Ferenčík, M., Škárka, B. et al. (1981) Biochemical laboratory methods. Bratislava, Alfa, 856 pp. (in Slovak).Google Scholar
  15. Freijd, A., Hammarstrom, L., Persson, M. A. and Smith, C. I. (1984) Plasma antipneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin. Exp. Immunol. ,56, 233–8.Google Scholar
  16. Gronski, P., Kanzy, E. J., Ronneberger, H. J., Geursen, R. and Seiler, F. R. (1986) Quality criteria for i.v. immunoglobulins: importance of tests and product properties. Behring. Ins. Mitt. ,80, 16–30. Jungi, T. W., Eiholzer, J., Lerch, P. G. and Barandun, S. (1986) The capacity of various types of immunoglobulin for intravenous use to interact with Fc receptors of human monocytes and macrophages. Blut ,53, 321–32.Google Scholar
  17. McCue, J. P., Hein, R. H. and Tenold, R. (1986) Three generations of immunoglobulin G preparations for clinical use. Rev. Infect. Dis. ,8, suppl. 4, S374–81.CrossRefGoogle Scholar
  18. Montanaro, A. and Pirofsky, B. (1984) Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Amer. J. Med. ,76, 67–72.CrossRefGoogle Scholar
  19. Morell, A. and Nydegger, U. E. (eds.) (1986) Clinical use of intravenous immunoglobulins. London, Acad. Press, 460 pp.Google Scholar
  20. Newland, A. C. (1988) Clinical use of intravenous immunoglobulin in blood disorders. Blood Rev. ,2, 157–67.CrossRefGoogle Scholar
  21. Pirofsky, B. (1984) Intravenous immune globulin therapy in hypogamma-globulinaemia. A review. Amer. J. Med. ,76, 53–60.CrossRefGoogle Scholar
  22. Rogers, T. R., Riches, P. G., Walker, S. A. and Joshi, R. (1986) Changes in immunoglobulin levels and implications for immunoglobulin therapy to prevent infection following bone marrow transplantation. In: Morell, A. and Nydegger, U. E. (eds.), Clinical Use of Intravenous Immunoglobulins. London, Acad. Press, pp. 107–16.Google Scholar
  23. Smith, T. F. and Barn, R. P. (1986). IgG subclasses in children with chronic chest symptoms. Monogr. Allergy ,20, 119–27.Google Scholar
  24. Sultan, Y., Kazatchkine, M. E., Maisonneuve, P. and Nydegger, U. E. (1984) Anti-idiotype suppression of auto-antibodies to factor VIII by high dose intravenous gammaglobulin. Lancet ,1, 765–8.CrossRefGoogle Scholar
  25. Tiselius, A. and Kabat, E. A. (1939) An electrophoretic study of immune sera and purified antibody preparations. J. Exp. Med. ,69, 119–31.CrossRefGoogle Scholar
  26. Tsubakio, T., Kurata, Y. and Katagiri, S. (1983) Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gammaglobulin therapy in patients with ITP. Clin. Exp. Immunol. ,53, 697–702.Google Scholar
  27. WHO Expert Committee on Biological Standardization (1982) Report of an informal meeting on intravenous immunoglobulins (human), Geneva, Bull. WHO ,60, 43–7.Google Scholar
  28. Yount, W. J., Dorner, M. M., Kunkel, H. G. and Kabat, E. A. (1968) Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J. Exp. Med., 127 ,633–46.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1993

Authors and Affiliations

  • Miroslav Ferenčík
    • 1
  1. 1.Institute of Immunology, Faculty of MedicineComenius UniversityBratislavaCzechoslovakia

Personalised recommendations